Egetis Therapeutics AB: Funding, Investors & Team (Oct 2026)
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
Egetis Therapeutics AB has raised $65.0M across 2 funding rounds on record, the most recent an undisclosed round of $38.3M announced in Apr 2026.
That round is in line with the $38M median round size for Pharmaceutical Manufacturing companies tracked on FundedIQ over the last two years.
Egetis Therapeutics AB Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Egetis Therapeutics AB Funding Rounds
Egetis Therapeutics AB raised $26.7M in an undisclosed round announced in Oct 2023.
2.5 years later, an undisclosed round of $38.3M was announced in Apr 2026.
Egetis Therapeutics AB Founders and Leadership Team
Contact details for the Egetis Therapeutics AB team: 1 of 2 have an email address on file.
Start 14-day free trial →Egetis Therapeutics AB Funding Compared to Other Pharmaceutical Manufacturing Startups
Egetis Therapeutics AB's latest round of $38.3M is in line with the median round in Pharmaceutical Manufacturing. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Egetis Therapeutics AB in Pharmaceutical Manufacturing and Stockholm
Companies Similar to Egetis Therapeutics AB
India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and…
Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced…
LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription…
Yazen is a digital healthcare provider that offers tailored weight loss programs, combining medical…
Amelle provides AI software for AML risk assessments and KYC documentation for accounting firms.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
At IPercept, we offer software solutions and services that utilize artificial intelligence and hardware to…
AI sales assistant that eliminates administrative work for revenue teams
Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every…
We make wireless hardware that offers best-in-class performance, size and weight.
Tandem Health is focused on delivering healthcare services, while Tandem enables users to easily document…
Egetis Therapeutics AB Funding FAQs
What does Egetis Therapeutics AB do?
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
How much funding has Egetis Therapeutics AB raised?
Egetis Therapeutics AB has raised $65.0M across 2 rounds on record. The most recent is an undisclosed round of $38.3M announced in Apr 2026.
When did Egetis Therapeutics AB last raise funding?
Egetis Therapeutics AB's most recent funding round on record is an undisclosed round of $38.3M, announced in Apr 2026.
Who founded Egetis Therapeutics AB?
FundedIQ lists Nicklas Westerholm (Founder), Yilmaz M (Founder) at Egetis Therapeutics AB.
Where is Egetis Therapeutics AB headquartered?
Egetis Therapeutics AB is based in Stockholm, Stockholms Lan, Sweden.
How many employees does Egetis Therapeutics AB have?
Egetis Therapeutics AB is in the 11-50 employee band.
How does Egetis Therapeutics AB's funding compare to other Pharmaceutical Manufacturing startups?
Egetis Therapeutics AB's latest round of $38.3M is in line with the $38M median round size for Pharmaceutical Manufacturing companies on FundedIQ across 7 tracked companies over the last two years.
About FundedIQ's Egetis Therapeutics AB Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Egetis Therapeutics AB is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.